TrialBMC endocrine disorders2026

Beyond glycemic control: differential effects of empagliflozin and sitagliptin on insulin sensitivity and a shared increase in adropin in type 2 diabetes.

Otbah Salim Taha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.